UTILIZATION STUDY OF DABIGATRAN ETEXILATE IN HOSPITALIZED PATIENTS

Objective: To define the utilization profile of dabigatran etexilate in hospitalized patients. Method: Four-month observational prospective utilization study of the type prescription-indication. Data were obtained from pharmacological treatments of the electronic prescribing program, analytics and patients' clinical records. We reviewed their adaptation to the drug's data sheet and the hospital's utilization protocol. We recorded any adverse drug reactions. Results: 138 patients began treatment with dabigatran etexilate. In 89.13% of patients, dabigatran was prescribed for the approved indication in the data sheet, while in 10.87% it was used for other indications. 57.24% of prescriptions were adapted to the hospital's protocol and the data sheet. Conclusion: The use of dabigatran has been adequate for the majority of patients.